What is the ticker symbol for Syndax Pharmaceuticals?

Syndax Pharmaceuticals trades under the ticker SNDX on NASDAQ.

What sector does Syndax Pharmaceuticals operate in?

Syndax Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SNDX in a portfolio?

PortView shows SNDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Syndax Pharmaceuticals (SNDX) Stock Analysis

NASDAQHealthcareBiotechnology

$20.18+0.40%

1-year price historyRange $13.11 – $25.15

52-week range$20.18

$12.99$25.59

What Syndax Pharmaceuticals does

Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML). Another significant candidate is SNDX-6352, or axatilimab, a monoclonal antibody designed to block the colony stimulating factor 1 (CSF-1) receptor, intended for patients suffering from chronic graft versus host disease (cGVHD). The company is additionally progressing Entinostat. Syndax has also established strategic collaborations, including a research and development agreement with the National Cancer Institute, a clinical trial agreement with the Eastern Cooperative Oncology Group, and a license agreement with Kyowa Hakko Kirin Co., Ltd. Founded in 2005, Syndax Pharmaceuticals, Inc. maintains its corporate headquarters in Waltham, Massachusetts.

Key metrics

Market cap

$1.79B

P/E (TTM)

-8.04

EPS (TTM)

$-2.51

Beta

0.37

Dividend yield

0.00%

Revenue / share

$2.83

50-day avg

$20.89

200-day avg

$20.92

52-week high

$25.59

52-week low

$12.99

CEO

Michael A. Metzger

ETFs linked to SNDX

Broad-market and Healthcare sector ETFs an investor holding Syndax Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SNDX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SNDX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Syndax Pharmaceuticals?: Syndax Pharmaceuticals trades under the ticker SNDX on NASDAQ.
Which exchange is SNDX listed on?: SNDX is listed on NASDAQ.
What sector does Syndax Pharmaceuticals operate in?: Syndax Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SNDX in a portfolio?: PortView shows SNDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.